Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - GoodwillEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares OutstandingWages, Salaries and Other
Ratios

Harvard Bioscience (HBIO) Accumulated Depreciation & Amortization (2016 - 2024)

Historic Accumulated Depreciation & Amortization for Harvard Bioscience (HBIO) over the last 16 years, with Q4 2024 value amounting to $15.8 million.

  • Harvard Bioscience's Accumulated Depreciation & Amortization rose 997.57% to $15.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $15.8 million, marking a year-over-year increase of 997.57%. This contributed to the annual value of $15.8 million for FY2024, which is 997.57% up from last year.
  • Latest data reveals that Harvard Bioscience reported Accumulated Depreciation & Amortization of $15.8 million as of Q4 2024, which was up 997.57% from $14.4 million recorded in Q4 2023.
  • In the past 5 years, Harvard Bioscience's Accumulated Depreciation & Amortization ranged from a high of $16.6 million in Q4 2020 and a low of $14.4 million during Q4 2023
  • Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $15.1 million (2020), whereas its average is $15.2 million.
  • Over the last 5 years, Harvard Bioscience's Accumulated Depreciation & Amortization had its largest YoY gain of 1109.1% in 2020, and its largest YoY loss of 1565.11% in 2020.
  • Over the past 5 years, Harvard Bioscience's Accumulated Depreciation & Amortization (Quarter) stood at $16.6 million in 2020, then fell by 12.94% to $14.4 million in 2021, then grew by 2.75% to $14.8 million in 2022, then decreased by 3.11% to $14.4 million in 2023, then rose by 9.98% to $15.8 million in 2024.
  • Its last three reported values are $15.8 million in Q4 2024, $14.4 million for Q4 2023, and $14.8 million during Q4 2022.